Registry › XF-7SS8DZ4-U
XF-7SS8DZ4-U
Second Party Opinion ACTIVE

ISS ESG Second Party Opinion — Royalty Pharma plc

Document Metadata

Issuer
Royalty Pharma plc
Document Type
Second Party Opinion
Publication Year
2021
Retrieved
20 March 2026
Source
Contact XFID for Access
Record ID
XF7SS8DZ4U
Validation
Inferred by XFID

Verification

XFIDs are content-addressed: these SHA-256 fingerprints let anyone confirm a copy of this document is identical to what XFID retrieved on 20 March 2026 — independent of this registry.

SHA-256 (file bytes)
b109a2f386874b909d5d0df767db11bd1a420884015d85d7be241db66e1ca123
SHA-256 (canonical content)
30e58ffe31818f10814e40355885daf100eb6f6417ce54b0abbf8ace23dc82e7
File
844 KB

The canonical-content hash survives re-downloads, URL moves, and byte-level re-encodes: the same disclosure text always resolves to this XFID.

Assessment Provider

ISS ESG Provider

People Cited in This Document

Version History

Retrieved Action Size
20/03/2026 INITIAL 844 KB latest

How to Cite This Record

Use the XFID in citations to create a stable, permanent reference that resolves to this registry entry regardless of the source URL.

Academic / report citation
Royalty Pharma plc (2021). ISS ESG Second Party Opinion — Royalty Pharma plc. XFID: XF-7SS8DZ4-U. Retrieved from https://xframework.id/XF7SS8DZ4U
Identifier only
XF-7SS8DZ4-U